WO2014184684A3 - Methods and biomarkers for detection of hematological cancers - Google Patents

Methods and biomarkers for detection of hematological cancers Download PDF

Info

Publication number
WO2014184684A3
WO2014184684A3 PCT/IB2014/001733 IB2014001733W WO2014184684A3 WO 2014184684 A3 WO2014184684 A3 WO 2014184684A3 IB 2014001733 W IB2014001733 W IB 2014001733W WO 2014184684 A3 WO2014184684 A3 WO 2014184684A3
Authority
WO
WIPO (PCT)
Prior art keywords
biomarkers
samples
detection
methods
hematological cancers
Prior art date
Application number
PCT/IB2014/001733
Other languages
French (fr)
Other versions
WO2014184684A2 (en
Inventor
Guro Elisabeth LIND
Erlend Bremertun SMELAND
Ragnhild A. Lothe
Original Assignee
Oslo Universitetssykehus Hf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oslo Universitetssykehus Hf filed Critical Oslo Universitetssykehus Hf
Publication of WO2014184684A2 publication Critical patent/WO2014184684A2/en
Publication of WO2014184684A3 publication Critical patent/WO2014184684A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to methods and biomarkers (e.g., epigenetic biomarkers) for detection of hematological cancers (e.g., lymphoma) in biological samples (e.g., tissue samples, blood samples, plasma samples, cell samples, serum samples).
PCT/IB2014/001733 2013-05-16 2014-05-15 Methods and biomarkers for detection of hematological cancers WO2014184684A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361824278P 2013-05-16 2013-05-16
US61/824,278 2013-05-16

Publications (2)

Publication Number Publication Date
WO2014184684A2 WO2014184684A2 (en) 2014-11-20
WO2014184684A3 true WO2014184684A3 (en) 2015-05-21

Family

ID=51585136

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2014/001733 WO2014184684A2 (en) 2013-05-16 2014-05-15 Methods and biomarkers for detection of hematological cancers

Country Status (1)

Country Link
WO (1) WO2014184684A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017059902A1 (en) 2015-10-07 2017-04-13 Biontech Rna Pharmaceuticals Gmbh 3' utr sequences for stabilization of rna
CA3111887A1 (en) 2018-09-27 2020-04-02 Grail, Inc. Methylation markers and targeted methylation probe panel
CA3127894A1 (en) * 2019-02-05 2020-08-13 Grail, Inc. Detecting cancer, cancer tissue of origin, and/or a cancer cell type

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007050706A2 (en) * 2005-10-27 2007-05-03 University Of Missouri-Columbia Dna methylation biomarkers in lymphoid and hematopoietic malignancies
US20100273151A1 (en) * 2004-05-28 2010-10-28 Fred Hutchinson Cancer Research Center Genome-wide analysis of palindrome formation and dna methylation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US5639611A (en) 1988-12-12 1997-06-17 City Of Hope Allele specific polymerase chain reaction
CA2036946C (en) 1990-04-06 2001-10-16 Kenneth V. Deugau Indexing linkers
US5494810A (en) 1990-05-03 1996-02-27 Cornell Research Foundation, Inc. Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease
US5338671A (en) 1992-10-07 1994-08-16 Eastman Kodak Company DNA amplification with thermostable DNA polymerase and polymerase inhibiting antibody
US5773258A (en) 1995-08-25 1998-06-30 Roche Molecular Systems, Inc. Nucleic acid amplification using a reversibly inactivated thermostable enzyme
US5965408A (en) 1996-07-09 1999-10-12 Diversa Corporation Method of DNA reassembly by interrupting synthesis
US7662594B2 (en) 2002-09-20 2010-02-16 New England Biolabs, Inc. Helicase-dependent amplification of RNA
AU2004270220B2 (en) 2003-09-05 2009-03-05 The Chinese University Of Hong Kong Method for non-invasive prenatal diagnosis
PT2385143T (en) 2006-02-02 2016-10-18 Univ Leland Stanford Junior Non-invasive fetal genetic screening by digital analysis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100273151A1 (en) * 2004-05-28 2010-10-28 Fred Hutchinson Cancer Research Center Genome-wide analysis of palindrome formation and dna methylation
WO2007050706A2 (en) * 2005-10-27 2007-05-03 University Of Missouri-Columbia Dna methylation biomarkers in lymphoid and hematopoietic malignancies

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
GARNIS CATHIE ET AL: "Overexpression of LRP12, a gene contained within an 8q22 amplicon identified by high-resolution array CGH analysis of oral squamous cell carcinomas", ONCOGENE, NATURE PUBLISHING GROUP, GB, vol. 23, no. 14, 1 April 2004 (2004-04-01), pages 2582 - 2586, XP002500728, ISSN: 0950-9232, DOI: 10.1038/SJ.ONC.1207367 *
M. DAIBATA ET AL: "Promoter Hypermethylation of the Bone Morphogenetic Protein-6 Gene in Malignant Lymphoma", CLINICAL CANCER RESEARCH, vol. 13, no. 12, 15 June 2007 (2007-06-15), pages 3528 - 3535, XP055157346, ISSN: 1078-0432, DOI: 10.1158/1078-0432.CCR-06-2766 *
R. SHAKNOVICH ET AL: "DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma", BLOOD, vol. 116, no. 20, 7 July 2010 (2010-07-07), pages e81 - e89, XP055158085, ISSN: 0006-4971, DOI: 10.1182/blood-2010-05-285320 *
SMELAND: "Epigenetic mechanisms in the development of malignant lymphoma - Centre for Cancer Biomedicine", 10 February 2012 (2012-02-10), XP055156533, Retrieved from the Internet <URL:http://www.med.uio.no/ccb/english/research/groups/erlend-smeland/projects-smeland/epigenetic-mechanisms-in-the-development-of-malignant-lymphoma/> [retrieved on 20141203] *
UCCELLA S ET AL: "MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression", JOURNAL OF CLINICAL PATHOLOGY, BMJ PUBLISHING GROUP, GB, vol. 62, no. 8, 1 August 2009 (2009-08-01), pages 715 - 723, XP008173783, ISSN: 0021-9746, DOI: 10.1136/JCP.2009.064741 *
ZHAOHUI WANG ET AL: "Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas", JOURNAL OF TRANSLATIONAL MEDICINE, BIOMED CENTRAL, LONDON, GB, vol. 10, no. 1, 11 October 2012 (2012-10-11), pages 209, XP021134187, ISSN: 1479-5876, DOI: 10.1186/1479-5876-10-209 *

Also Published As

Publication number Publication date
WO2014184684A2 (en) 2014-11-20

Similar Documents

Publication Publication Date Title
WO2014028378A3 (en) Methods and systems for detecting biological components
MX2018006430A (en) Nucleic acid sample preparation.
EP3076949A4 (en) Analysis of genomic dna, rna, and proteins in exosomes for diagnosis and theranosis
WO2014144822A3 (en) Methods and compositions for tagging and analyzing samples
EP3175247A4 (en) Instrument for analyzing biological samples and reagents
EP3971299A3 (en) Colorectal cancer detection kit or device, and detection method
HK1208284A1 (en) Deep-maldi tof mass spectrometry of complex biological samples, e.g., serum, and uses thereof maldi tof
WO2013132305A8 (en) Size-based analysis of fetal dna fraction in maternal plasma
EP3967769A3 (en) Lung cancer detection kit or device, and detection method
WO2013086429A3 (en) Methods and compositions for classification of samples
EP3080585A4 (en) Biosensors for biological or chemical analysis and methods of manufacturing the same
WO2011088014A3 (en) Systems and methods for counting cells and biomolecules
WO2012021795A3 (en) Pancreatic cancer biomarkers and uses thereof
WO2011100708A3 (en) Assay card for sample acquisition, treatment and reaction
EP4024029A3 (en) Systems and methods for sample use maximization
EP3654036A3 (en) Stomach cancer biomarker and detection method
EP3608021A3 (en) Analyte detection devices, multiplex and tabletop devices for detection of analytes, and uses thereof
WO2009121032A3 (en) Sample preparation devices and methods for processing analytes
NZ621733A (en) Lung cancer biomarkers and uses thereof
WO2011106709A3 (en) Epithelial biomarkers for cancer prognosis
EP4324937A3 (en) Detecting hematological disorders using cell-free dna in blood
NZ629555A (en) Monocyte biomarkers for cancer detection
WO2012120374A3 (en) Methods and biomarkers for detection of gastrointestinal cancers
WO2013026026A3 (en) Shift correction for spectral analysis
WO2013124738A3 (en) Methods and biomarkers for detection and prognosis of cervical cancer

Legal Events

Date Code Title Description
122 Ep: pct application non-entry in european phase

Ref document number: 14771619

Country of ref document: EP

Kind code of ref document: A2